P. Dodion
- Oncology top 10%
- Cancer Treatment and Pharmacology 28
- HER2/EGFR in Cancer Research 5
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 5
- Obstetrics and Gynecology top 10%
- Reproductive Medicine top 10%
-
- Cancer therapeutics and mechanisms 13
- Biochemical and Molecular Research 5
-
- Chemotherapy-induced cardiotoxicity and mitigation 9
-
- Chemotherapy-related skin toxicity 7
-
- Brain Metastases and Treatment 4
P. Dodion
70 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 97
- Oncology 446
- Otorhinolaryngology 60
- Obstetrics and Gynecology 88
- Reproductive Medicine 86
- Cancer Research 106
Countries citing papers authored by P. Dodion
This map shows the geographic impact of P. Dodion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Dodion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Dodion more than expected).
Fields of papers citing papers by P. Dodion
This network shows the impact of papers produced by P. Dodion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Dodion. The network helps show where P. Dodion may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. Dodion, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 82 | |
| 2 | 2012 | 30 | |
| 3 | 1993 | 10 | |
| 4 | 1991 | 11 | |
| 5 | 1990 | 1 | |
| 6 | 1990 | 36 | |
| 7 | 1990 | 28 | |
| 8 | 1990 | 31 | |
| 9 | 1989 | 2 | |
| 10 | 1989 | 4 | |
| 11 | 1988 | 7 | |
| 12 | 1988 | 16 | |
| 13 | Loss of fluorescence by anthracycline antibiotics: effects of xanthine oxidase and identification of the nonfluorescent metabolites. | 1987 | 11 |
| 14 | 1987 | 7 | |
| 15 | 1987 | 4 | |
| 16 | 1987 | 3 | |
| 17 | 1987 | 18 | |
| 18 | 1987 | 92 | |
| 19 | 1986 | 21 | |
| 20 | Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in squamous cell carcinoma of the head and neck | 1982 | 1 |
About P. Dodion
P. Dodion is a scholar working on Oncology, Otorhinolaryngology and Dermatology, having authored 72 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (28 papers), Cancer therapeutics and mechanisms (13 papers), Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Chemotherapy-related skin toxicity (7 papers), Biochemical and Molecular Research (5 papers), HER2/EGFR in Cancer Research (5 papers), Head and Neck Cancer Studies (5 papers) and Brain Metastases and Treatment (4 papers). The work is most often cited by research in Oncology (446 citations), Otorhinolaryngology (60 citations) and Obstetrics and Gynecology (88 citations). P. Dodion has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Marcel Rozencweig, Frank G. Haluska, J. Renard, M. Clavel, Herbert M. Pinedo, S. Gundersen, U. Bruntsch, M. van Glabbeke, R Abele and Martine Piccart. Their work appears in journals such as Annals of Oncology, Investigational New Drugs, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.